InvestorsHub Logo
Followers 85
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: ststephensrevenge post# 185160

Monday, 08/04/2014 12:57:31 AM

Monday, August 04, 2014 12:57:31 AM

Post# of 346441
nice.... ! nice post there! Now I am confident that news is coming soon.

I remember your argument back in 2012 as you stated in one of your posts:

forcefully remove these folks from the reigns and watch this horse move.



Why is that argument not used any more? I wonder if the vote last ASM forcefully remove folks from using that argument any more? No matter, and I see now you're tagging along with the rest of the Dew Crew and hanging your hat on the new round of general comments:

A realistic expectation of 2016 is most likely where it will pan out.



Thanks again,

I am confident as ever that news will arrive shortly.

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News